🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Jacobs (JEC) Signs Technology Licensor Deal With Paqell

Published 10/11/2017, 10:44 PM
Updated 07/09/2023, 06:31 AM
SHEL
-
AMZN
-
J
-
BZH
-
AERI
-
IBP
-

Jacobs Engineering Group Inc. (NYSE:JEC) recently inked a sulfur-recovery technology licensor covenant with Paqell. Per the deal, Pagell would be able to use Jacob’s state-of-the-art THIOPAQ Oil and Gas (O&G) technology in all of its gas-treating facilities and refineries across the world.

Over the last six months, Jacobs’ shares yielded a return of 9.5%, outperforming 5.4% growth recorded by the industry.

Notably, the company’s earnings per share are projected to be up nearly 8.7% in the next three to five years.

Inside the Headlines

THIOPAQ is a unique constituent of Jacobs’ Comprimo Sulfur Solutions technology portfolio. Comprimo Sulfur Solutions offers engineering, licensing, construction and procurement services to sulfur recovery and gas-treating plants worldwide. These services assist in expanding plant-processing capacity, boosting sulfur-recovery efficiency and integrating new units to facilities.

THIOPAQ O&G technology is a unique biological process which helps assimilate gas purification, along with sulfur recovery in a singular unit, giving rise to high sulfur-recovery levels. Such high recovery levels help reduce operating and installation costs of facilities. The technology is rapidly gaining importance these days, as it is an effective solution for chemical-waste reduction (causing safety and environmental hazards).

Per the aforementioned agreement, Jacobs’ THIOPAQ O&G technology will be used to lower chemical-waste release from the gas-treating facilities and refineries of Paqell — a joint venture business between Paques BV and Shell (LON:RDSa) Global Solutions.

Contract-Based Growth

Since the beginning of September 2017, Jacobs has secured contracts from Evonik Industries, Department of Energy National Nuclear Security Administration (NNSA), Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) and Ferring Pharmaceuticals Inc. Notably, Jacobs has also signed an agreement (Aug 7, 2017) to acquire CH2M HILL Companies Ltd., which is in sync with its efforts to become a $15-billion global solutions provider over the long run.

The company quotes competitive prices for its contracts and ensures that the number of contract receipts increases over time. Notably, elevated transportation spending of the government authorities of Australia, the U.K. and the United States has largely increased the company’s contract-winning opportunities.

Stocks to Consider

Installed Building Products, Inc. (NYSE:IBP) carries a Zacks Rank #2 (Buy) and generated an average positive earnings surprise of 0.67% in the last four quarters. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Beazer Homes USA, Inc. (NYSE:BZH) also holds a Zacks Rank #2 and pulled off an outstanding average positive earnings surprise of 103.47% during the same time frame.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Installed Building Products, Inc. (IBP): Free Stock Analysis Report

Jacobs Engineering Group Inc. (JEC): Free Stock Analysis Report

Beazer Homes USA, Inc. (BZH): Free Stock Analysis Report

Aerie Pharmaceuticals, Inc. (AERI): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.